Pfizer data shows vaccine protection remains robust six months after vaccination even as the company argues that boosters will be needed

While company data showed a slight drop in efficacy against any symptomatic cases of covid-19, from 96 percent protection in the first two months following vaccination to 84 percent after four months, the vaccine was 97 percent effective against severe disease.

View original article
Contributor: Carolyn Y. Johnson